AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
ESOMEPRAZOLE MAGNESIUM in Zimbabwe
7 products registered with MCAZ — 7 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ESOZ-40 TABLET, COATED; ORAL | 2004/16.5.6/4235 | GLENMARK PHARMACEUTICALS LTD | active | 24 Apr 2030 |
| ESOZ-20 TABLET, COATED; ORAL | 2004/16.5.6/4234 | GLENMARK PHARMACEUTICALS LTD | active | 24 Apr 2030 |
| NEXIUM TABLET, COATED; ORAL | 2005/16.7/4349 | INDUSTRIAL CHEMICAL IMPORTERS | active | 31 Dec 2027 |
| ESOPREX 20 TABLET, COATED; ORAL | 2021/16.7/6116 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
| ESOPREX 40 TABLET, COATED; ORAL | 2021/16.7/6117 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
| SKY PHARM- ESOMEPRAZOLE TABLET, COATED; ORAL | 2018/16.7/5646 | ADVENTURA INVESTMENTS LIMITED | active | 31 Dec 2027 |
| NEXIUM TABLET, COATED; ORAL | 2005/16.7/4350 | INDUSTRIAL CHEMICAL IMPORTERS | active | 31 Dec 2027 |
ESOMEPRAZOLE MAGNESIUM — MCAZ Registration Details
MCAZ (Zimbabwe) has 7 registered products containing ESOMEPRAZOLE MAGNESIUM, of which 7 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track ESOMEPRAZOLE MAGNESIUM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.